Metirra

Metirra is a biotechnology company based in Indianapolis, Indiana, focused on developing next-generation radiopharmaceuticals for the treatment of cancer. The company was founded by a team of industry veterans with extensive experience in radioligand therapy, including former executives from Endocyte and Point Biopharma. Metirra leverages its expertise in ligand design and radiochemistry to create targeted therapies that deliver radioactive isotopes directly to tumor cells while minimizing damage to healthy tissue. The company's platform is designed to optimize the therapeutic index of radioligands, addressing unmet needs in the oncology space. Currently in the pre-clinical stage, Metirra is building a pipeline of candidates aimed at various solid tumor indications.